Lieve Coenegrachts

1.3k total citations
16 papers, 571 citations indexed

About

Lieve Coenegrachts is a scholar working on Obstetrics and Gynecology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lieve Coenegrachts has authored 16 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Obstetrics and Gynecology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Lieve Coenegrachts's work include Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Lieve Coenegrachts is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Lieve Coenegrachts collaborates with scholars based in Belgium, United States and Australia. Lieve Coenegrachts's co-authors include Frédéric Amant, Diether Lambrechts, Geert Carmeliet, Jorina Geys, Abderrahim Nemmar, Jo Vercammen, Benoît Nemery, Stefanie Schrauwen, Yves Engelborghs and Peter Hoet and has published in prestigious journals such as The EMBO Journal, Cancer Research and Journal of Bone and Mineral Research.

In The Last Decade

Lieve Coenegrachts

15 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lieve Coenegrachts Belgium 11 227 158 142 112 103 16 571
Tao‐Yeuan Wang Taiwan 18 378 1.7× 207 1.3× 131 0.9× 141 1.3× 127 1.2× 53 1.0k
Minmin Song China 14 224 1.0× 233 1.5× 130 0.9× 145 1.3× 75 0.7× 26 718
Panimaya Jeffreena Miranda Australia 8 441 1.9× 140 0.9× 236 1.7× 36 0.3× 37 0.4× 12 681
Ling Ma United States 11 107 0.5× 176 1.1× 52 0.4× 25 0.2× 177 1.7× 17 388
Joëlle d'Anjou France 12 192 0.8× 146 0.9× 95 0.7× 114 1.0× 62 0.6× 21 584
Elizabeth Masse United States 7 370 1.6× 159 1.0× 167 1.2× 16 0.1× 87 0.8× 8 625
Krzysztof Sobolewski Poland 14 208 0.9× 47 0.3× 66 0.5× 192 1.7× 78 0.8× 51 826
Yuen Nakase Japan 18 453 2.0× 184 1.2× 126 0.9× 12 0.1× 179 1.7× 58 1.1k
Kui Meng China 10 135 0.6× 63 0.4× 79 0.6× 67 0.6× 63 0.6× 30 431

Countries citing papers authored by Lieve Coenegrachts

Since Specialization
Citations

This map shows the geographic impact of Lieve Coenegrachts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieve Coenegrachts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieve Coenegrachts more than expected).

Fields of papers citing papers by Lieve Coenegrachts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieve Coenegrachts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieve Coenegrachts. The network helps show where Lieve Coenegrachts may publish in the future.

Co-authorship network of co-authors of Lieve Coenegrachts

This figure shows the co-authorship network connecting the top 25 collaborators of Lieve Coenegrachts. A scholar is included among the top collaborators of Lieve Coenegrachts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieve Coenegrachts. Lieve Coenegrachts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Depreeuw, Jeroen, Els Hermans, Stefanie Schrauwen, et al.. (2015). Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies. Gynecologic Oncology. 139(1). 118–126. 42 indexed citations
3.
Schrauwen, Stefanie, et al.. (2015). The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo. Gynecologic Oncology. 138(2). 378–382. 6 indexed citations
4.
Coenegrachts, Lieve, Jeroen Depreeuw, Marı́a Santacana, et al.. (2015). Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(4). 415–422. 23 indexed citations
5.
Coenegrachts, Lieve, Jeroen Depreeuw, Godelieve Verbist, et al.. (2015). Microsatellite Instable and Microsatellite Stable Primary Endometrial Carcinoma Cells and Their Subcutaneous and Orthotopic Xenografts Recapitulate the Characteristics of the Corresponding Primary Tumor. International Journal of Gynecological Cancer. 25(3). 363–371. 6 indexed citations
6.
Maiques, Óscar, Lieve Coenegrachts, Marı́a Santacana, et al.. (2014). FISH analysis ofPTENin endometrial carcinoma. comparison withSNParrays andMLPA. Histopathology. 65(3). 371–388. 3 indexed citations
7.
Zhao, Hui, Bernard Thienpont, Betül T. Yesilyurt, et al.. (2014). Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks. eLife. 3. e02725–e02725. 64 indexed citations
8.
Lambrechts, Diether, Lieve Coenegrachts, Ingrid Vandenput, et al.. (2012). High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecologic Oncology. 128(2). 327–334. 63 indexed citations
9.
Coenegrachts, Lieve, Stefanie Schrauwen, Rita van Bree, et al.. (2012). Increased expression of placental growth factor in high-grade endometrial carcinoma. Oncology Reports. 29(2). 413–418. 12 indexed citations
10.
Vandenput, Ingrid, Lieve Coenegrachts, Godelieve Verbist, et al.. (2011). Expression of ERCC1, p53, and Class III A-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer. International Journal of Gynecological Cancer. 21(6). 1071–1077. 11 indexed citations
11.
Amant, Frédéric, Thomas Tousseyn, Lieve Coenegrachts, et al.. (2011). Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype.. PubMed. 31(6). 2367–71. 16 indexed citations
12.
Coenegrachts, Lieve, Christa Maes, Sophie Torrekens, et al.. (2010). Anti–Placental Growth Factor Reduces Bone Metastasis by Blocking Tumor Cell Engraftment and Osteoclast Differentiation. Cancer Research. 70(16). 6537–6547. 40 indexed citations
13.
Maes, Christa, Steven Goossens, Sonia Bartunkova, et al.. (2009). Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones. The EMBO Journal. 29(2). 424–441. 164 indexed citations
14.
Maes, Christa, et al.. (2008). Dwarfism and Osteopenia in Mice with Inactivated Hypoxia-Response Element in the VEGF Gene Promoter. Journal of Bone and Mineral Research. 23.
15.
Coenegrachts, Lieve, et al.. (2007). The effect of microgravity on 1,25-dihydroxyvitamin d3 signalling in osteoblasts. Microgravity Science and Technology. 19(5-6). 154–158. 4 indexed citations
16.
Geys, Jorina, Lieve Coenegrachts, Jo Vercammen, et al.. (2005). In vitro study of the pulmonary translocation of nanoparticles. Toxicology Letters. 160(3). 218–226. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026